Avenue Biosciences technology collects data sets on how specific signal peptides impact specific protein targets.

The Open University of Kenya has announced 61 job opportunities for academic and administrative staff positions. In a notice ...

TVK chief and actor Vijay is set to appear before the Central Bureau of Investigation (CBI) in Delhi for questioning ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch. The analysts’ selections for the upcoming year span ...

Despite a year of trade tensions, national security strictures and stark warnings about the U.S.’ waning biotech innovation edge, the fact remains that China is and will likely continue to be a ...

The biotech sector has put up a strong recovery in 2025. The Nasdaq Biotechnology Index has risen 33.1% so far this year. The index bottomed out in April 2025 on potential imposition of steep tariffs, ...

“Biotech is making money again,” Mizuho Securities declared to cap off 2025. The sentiment was echoed across a handful of sector previews as analysts reflected on a turbulent year in life sciences.

2025 has largely been a year to forget for biotech IPOs. Already in the throes of a prolonged slowdown, new biotech stock offerings in 2025 reached their lowest levels in at least seven years. Data ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

SAN JOSE — Zebra Technologies and bioMerieux reported to the state Employment Development Department their separate decisions to cut jobs in moves that will eliminate a combined 196 positions in San ...